Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India
NCT ID: NCT02592057
Last Updated: 2018-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
532 participants
OBSERVATIONAL
2015-11-30
2018-04-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection
NCT02074514
Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection
NCT03074331
Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection
NCT01826981
Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients
NCT02576314
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV
NCT02671500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SOF-based regimens
Adults with chronic HCV infection in India who are being treated with a SOF-based treatment regimen as per the approved prescribing information.
SOF
SOF tablets administered orally once daily based on approved prescribing information
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SOF
SOF tablets administered orally once daily based on approved prescribing information
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treatment with a SOF-based regimen as determined by the patient's treating physician per the approved prescribing information.
* Patients who provide written and signed informed consent prior to initiation of treatment where required.
Exclusion Criteria
* Patients presenting a risk of not being able to be followed (eg, patients planning to move or leave the country in a foreseeable future)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gilead Sciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gilead Study Director
Role: STUDY_DIRECTOR
Gilead Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Global Hospitals
Hyderabad, Andhra Pradesh, India
A.I.I.M.S.
New Delhi, Ansari Nagar, India
Nirmal Hospital Pvt. Ltd.
Surat, Gujarat, India
Artemis Hospital
Gurgaon, Haryana, India
Manipal Hospital
Bengaluru, Karnataka, India
BGS global Hospitals
Bengaluru, Karnataka, India
Lakeshore Hospital
Kochi, Kerala, India
Midas Institute of Gastro-enterology
Nagpur, Maharashtra, India
S.R. Kalla Memorial Gastro & General Hospital
Jaipur, Rajasthan, India
SMS Medical College & Hospital
Jaipur, Rajasthan, India
Marudhar Hospital
Jaipur, Rajasthan, India
Global Hospitals & Health City
Chennai, Tamil Nadu, India
VGM Hospital
Coimbatore, Tamil Nadu, India
KGMU Medical College
Lucknow, Uttar Pradesh, India
Postgraduate Institute of Medical Education and Research
Chandigarh, Uttarakhand, India
Institute of Post Graduate Medical Education And Research
Kolkata, West Bengal, India
Sanjivani Superspeciality Hospital Clinical Research Department
Ahmedabad, , India
Saviour Hospital
Ahmedabad, , India
Sri Ramachandra Medical College and Research
Chennai, , India
Aware Global Hospital
Hyderabad, , India
M.V. Hospital and Research Centre
Lucknow, , India
K. R. M. Hospital & Research Centre
Lucknow, , India
Dayanand Medical College & Hospital
Ludhiana, , India
BYL Nair Hospital & T N Medical College
Mumbai, , India
Sir Ganga Ram Hospital
New Delhi, , India
Om Research Center, Om Surgical Center & Maternity Home
Varanasi, , India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GS-US-334-1775
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.